Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
796 Pegylated liposomal doxorubicin chemotherapy, Flt3 ligand, and CD40 agonist triplet combination improves tumor control in breast cancers
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 796 Pegylated liposomal doxorubicin chemotherapy, Flt3 ligand, and CD40 agonist triplet combination improves tumor control in breast cancers